Latest High-intensity focused ultrasound Stories
HAYWARD, Calif., Nov. 8, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the Lazard 9(th) Annual Healthcare Conference at the Pierre Hotel in New York on Tuesday, November 13, 2012 at 2:30 pm ET. Stephen J. Fanning, Chairman, President and Chief Executive Officer of Solta Medical, will review the company's business strategy and recent corporate events. Solta will offer a live video...
TIRAT CARMEL, Israel, October 22, 2012 /PRNewswire/ -- InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate(R) MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it...
HAYWARD, Calif., Oct. 11, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will release its financial results for the third quarter ended September 30, 2012, after market close on Tuesday, October 30, 2012. The Company will also host a conference call and webcast on Tuesday, October 30, 2012, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results and current corporate...
NEW YORK, Sept. 13, 2012 /PRNewswire/ -- Despite the best efforts of prostate cancer experts, the media, and widespread Prostate Cancer Awareness Month articles, the facts of prostate cancer recovery remain unclear to many. Dr. David Samadi, developer of the SMART (Samadi Modified Advanced Robotic Technique) robotic prostate surgery, helps men work through the common fears, worries, and even misconceptions about prostate cancer treatment and understand the beneficial role of...
TIRAT CARMEL, Israel, August 20, 2012 /PRNewswire/ -- InSightec [http://www.insightec.com ] Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration (FDA) to begin a Phase I clinical trial evaluating the use of its ExAblate(R) Neuro [http://www.insightec.com/ExAblate-Neuro.html ] system for the treatment of patients with tremor dominant Parkinson's Disease. Thirty patients who...
HAYWARD, Calif., Aug. 9, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the 32(nd) Annual Canaccord Growth Conference in Boston on August 14, 2012 at 1:00 pm ET. Stephen J. Fanning, Chairman, President and Chief Executive Officer of Solta Medical, will review the company's business strategy and recent corporate events. Solta will offer a live audio webcast of the presentation which...
NEW YORK, Aug. 8, 2012 /PRNewswire/ -- A recent study published in the Journal of Clinical Oncology reported that men who seek prostate cancer treatment from a team of specialists are more likely to defer treatment, a decision they extrapolated to mean better care. While you won't find Dr. David Samadi, leading robotic prostate cancer surgeon, and his colleagues at Mount Sinai Medical Center making the same blanket statement about postponing prostate cancer treatment, they are...
GULF SHORES, Ala., July 11, 2012 /PRNewswire/ -- Many patients find that after receiving image-guided cancer ablation, their bodies experience an anti-cancer immune response in which their immune system attacks untreated live tumors. Dr. Jason R. Williams of the American Cancer Ablation Center and Precision Imaging (http://www.cancerablation.com) is taking measures to enhance this response by combining the body's natural reaction to an ablated tumor with injections of...
From the air, the twists and turns of rivers can easily be seen. In the body, however, tracing the twists and turns of blood vessels is difficult, but important. Vessel "bendiness" can indicate the presence and progression of cancer. This principle led UNC scientists to a new method of using a high-resolution ultrasound to identify early tumors in preclinical studies. The method, based on vessel bendiness or "tortuosity," potentially offers an inexpensive, non-invasive and fast method to...
CHONGQING, China, July 10, 2012 /PRNewswire-Asia/ -- Zhang Dejiang, member of the Political Bureau of the CPC Central Committee, Chinese vice premier and the secretary of the CPC Chongqing Municipal Committee visited Chongqing HIFU Technology Co., Ltd in Chongqing Liangjiang New Area on July 6. In the area, Zhang Dejiang visited BAIC Motor's Chongqing Changke Rail Vehicle Co., Ltd., Hehejiayuan Residential Community, the Airport Functional Area of Lianglu Cuntan Bonded Port,...
